Cargando…
The Role of Mass Spectrometry and Proteogenomics in the Advancement of HLA Epitope Prediction
A challenge in developing personalized cancer immunotherapies is the prediction of putative cancer‐specific antigens. Currently, predictive algorithms are used to infer binding of peptides to human leukocyte antigen (HLA) heterodimers to aid in the selection of putative epitope targets. One drawback...
Autores principales: | Creech, Amanda L., Ting, Ying S., Goulding, Scott P., Sauld, John F.K., Barthelme, Dominik, Rooney, Michael S., Addona, Terri A., Abelin, Jennifer G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033110/ https://www.ncbi.nlm.nih.gov/pubmed/29314742 http://dx.doi.org/10.1002/pmic.201700259 |
Ejemplares similares
-
Variant biomarker discovery using mass spectrometry-based proteogenomics
por: Reilly, Luke, et al.
Publicado: (2023) -
Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopes
por: Poran, Asaf, et al.
Publicado: (2020) -
Proteogenomic Analysis of Mycobacterium smegmatis Using High Resolution Mass Spectrometry
por: Potgieter, Matthys G., et al.
Publicado: (2016) -
Proteogenomics
Reveal the Overexpression of HLA-I
in Cancer
por: Wang, Ying, et al.
Publicado: (2023) -
Sensitive, High-Throughput HLA-I and HLA-II Immunopeptidomics Using Parallel Accumulation-Serial Fragmentation Mass Spectrometry
por: Phulphagar, Kshiti Meera, et al.
Publicado: (2023)